Visa Inc.
V · NYSE
V · NYSE
Alphabet Inc. Depositary Shares representing a 1/20th Interest in a Share of Series A Mandatory Convertible Preferred Stock$50.64
Alphabet Inc. Depositary Shares representing a 1/20th Interest in a Share of Series B Mandatory Convertible Preferred Stock$50.35
Mastercard Incorporated$563.17
Oracle Corporation$151.05Visa operates a global payment-technology network that enables transactions among consumers, merchants, financial institutions and other participants. It makes money primarily through payments-related network, processing and service fees associated with the movement of payment volume, while its BioCatch agreement adds behavioral fraud-intelligence capabilities. The supplied evidence does not provide a segment breakdown or contributions by business line. Visa reports FY2025 revenue of $40.0 billion and net income of $20.1 billion, up from $35.9 billion and $19.7 billion, respectively, in FY2024, demonstrating its current multibillion-dollar operating scale.
Visa rose 0.82% over the supplied week, from $366.59 to $369.59. The stock initially climbed to $368.73 on July 29, then gave back that gain over the next two sessions, closing at $366.13 on July 31. It slipped another 0.13% on August 3 before rebounding 1.07% on August 4. The most relevant company-specific development was Visa’s agreement to acquire BioCatch for $2.4 billion in cash, expanding fraud-protection capabilities as AI-driven scams and account-takeover fraud increase. The evidence does not identify an earnings release or other operating catalyst during the week, so the acquisition appears to be the principal disclosed driver, although the price reaction was modest.